J. Gage

发表

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer

M. Schiffman, P. Castle, T. Lorey, 2018, Annals of Internal Medicine.

Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer

M. Schiffman, S. Hewitt, P. Luhn, 2017, International journal of cancer.

An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening

Mayoore S. Jaiswal, L. R. Long, Kai Yu, 2019, Obstetrical & Gynecological Survey.

Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.

M. Schiffman, N. Wentzensen, Joan L. Walker, 2017, Obstetrics and gynecology.

Follow-up care of women with an abnormal cytology in a low-resource setting.

C. Ferreccio, J. Gage, S. Robles, 2003, Cancer detection and prevention.

Effectiveness safety and acceptability of cryotherapy: a systematic literature review.

C. Ferreccio, L. Gaffikin, J. Sellors, 2003 .

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

M. Schiffman, P. Castle, T. Raine-Bennett, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS).

M. Schiffman, T. Raine-Bennett, T. Lorey, 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening.

Mayoore S. Jaiswal, L. R. Long, Kai Yu, 2019, Journal of the National Cancer Institute.

Interrater agreement of anal cytology

P. Castle, T. Lorey, S. Follansbee, 2013, Cancer cytopathology.

Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM

N. Wentzensen, P. Castle, T. Lorey, 2012, AIDS.

The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics

Nicole E. Varnado, N. Wentzensen, P. Castle, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings?

M. Schiffman, P. Castle, T. Raine-Bennett, 2017, Journal of Clinical Microbiology.

Response: Re: Preventing Cervical Cancer Globally by Acting Locally: If Not Now, When?

P. Castle, J. Gage, 2011 .

Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.

P. Castle, T. Alonzo, M. Cremer, 2018, Preventive medicine.

Why does cervical cancer occur in a state-of-the-art screening program?

M. Schiffman, P. Castle, T. Lorey, 2017, Gynecologic oncology.

Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines

M. Schiffman, N. Wentzensen, P. Castle, 2020, Journal of lower genital tract disease.

Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing

M. Schiffman, P. Castle, T. Raine-Bennett, 2018, Journal of Clinical Microbiology.

Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21–39 Years

M. Schiffman, P. Castle, T. Lorey, 2018, Cancer Prevention Research.

Comparison of the cobas Human Papillomavirus (HPV) Test with the Hybrid Capture 2 and Linear Array HPV DNA Tests

M. Schiffman, P. Castle, T. Lorey, 2011, Journal of Clinical Microbiology.

Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.

E. J. Mayeaux, M. Schiffman, A. Moscicki, 2017, Journal of lower genital tract disease.

Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city—Lessons learned from the Amazon city of Manaus, Brazil

A. Rodriguez, M. Schiffman, T. Raiol, 2021, PloS one.

Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.

P. Castle, T. Lorey, S. Follansbee, 2013, The Journal of infectious diseases.

Plasma cytokine levels and human papillomavirus infection at the cervix in rural Nigerian women.

S. Wacholder, M. Schiffman, N. Wentzensen, 2013, Cytokine.

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs

M. Schiffman, P. Castle, T. Raine-Bennett, 2020, EClinicalMedicine.

Spectroscopic imaging as triage test for cervical disease.

M. Schiffman, J. Gage, M. Safaeian, 2008, Journal of lower genital tract disease.

Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations.

P. Castle, J. Gage, M. Duggan, 2010, American journal of obstetrics and gynecology.

Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management

Kanan T. Desai, S. de Sanjosé, R. Burk, 2022, International journal of cancer.

Evidence that Taking More Cervical Biopsies Substantially Improves the Sensitivity of Colposcopically Guided Biopsies

M. Schiffman, D. Solomon, J. Gage, 2006 .

Running title: Novel Sampling Methods for HPV DNA Testing

S. Wacholder, P. Castle, E. Partridge, 2011 .

Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol

K. Anastos, P. Castle, J. Gage, 2022, BMJ Open.

Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador

P. Castle, T. Alonzo, Jane J. Kim, 2016, Journal of lower genital tract disease.

The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.

P. Castle, T. Alonzo, Jane J. Kim, 2019, Preventive medicine.

Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis

P. Castle, T. Alonzo, J. Felix, 2018, Journal of lower genital tract disease.

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection

Mark Schiffman, Allan Hildesheim, Sholom Wacholder, 2012, BMC Infectious Diseases.

Number of Cervical Biopsies and Sensitivity of Colposcopy

Diane Solomon, Mark Schiffman, Jose Jeronimo, 2006, Obstetrics and gynecology.

A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.

P. Castle, Hannah P. Yang, D. Walmer, 2011, Journal of virological methods.

Comparative Risk of High-Grade Histopathology Diagnosis After a CIN 1 Finding in Endocervical Curettage Versus Cervical Biopsy

P. Castle, J. Gage, M. Duggan, 2013, Journal of lower genital tract disease.

Human papillomavirus testing in the prevention of cervical cancer.

S. Wacholder, M. Schiffman, N. Wentzensen, 2011, Journal of the National Cancer Institute.

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador

P. Castle, Jane J. Kim, J. Felix, 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program

P. Castle, I. Scarinci, J. Felix, 2015, BMC Public Health.

The comparative and cost‐effectiveness of HPV‐based cervical cancer screening algorithms in El Salvador

P. Castle, Jane J. Kim, J. Felix, 2015, International journal of cancer.

ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice

Nicolas Wentzensen, E. J. Mayeaux, Mark Schiffman, 2017, Journal of lower genital tract disease.

Claims for Missing or Damaged Print Issues

D. Milner, G. Clifford, Z. Xue, 2021 .

Risk assessment to guide cervical screening strategies in a large Chinese population

Y. Qiao, M. Schiffman, P. Castle, 2016, International journal of cancer.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test

M. Schiffman, H. Erlich, P. Castle, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink

Hanns Lochmuller, Ruth M Pfeiffer, Mark H Greene, 2018, International journal of cancer.

A cohort study of cervical screening using partial HPV typing and cytology triage

M. Schiffman, P. Castle, T. Raine-Bennett, 2016, International journal of cancer.

Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detected HPV infection

M. Schiffman, P. Castle, T. Lorey, 2015, International journal of cancer.

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta

P. Castle, E. Partridge, I. Scarinci, 2013, BMC Infectious Diseases.

A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria

S. Wacholder, M. Schiffman, N. Wentzensen, 2011, Infectious Agents and Cancer.

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage

L. R. Long, Kanan T. Desai, M. Schiffman, 2020, Infectious agents and cancer.

A Comparison of Dacron versus Flocked Nylon Swabs for Anal Cytology Specimen Collection

N. Grabe, P. Castle, B. Lahrmann, 2011, Acta Cytologica.

Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral‐host interaction with implications for disease intervention

M. Yeager, Kai Yu, L. Burdett, 2020, International journal of cancer.

Accepting the universal truths of cervical human papillomavirus epidemiology in pursuit of the remaining mysteries.

M. Schiffman, J. Gage, M. Clarke, 2011, Sexually transmitted diseases.

Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men.

P. Castle, T. Lorey, S. Follansbee, 2013, The Journal of infectious diseases.

A Comparison of Human Papillomavirus Genotype-Specific DNA and E6/E7 mRNA Detection to Identify Anal Precancer among HIV-Infected Men Who Have Sex with Men

P. Castle, T. Lorey, A. Rodriguez, 2012, Cancer Epidemiology, Biomarkers & Prevention.

A Comparison of Human Papillomavirus Genotype-Speci ﬁ c DNA and E6/E7 mRNA Detection to Identify Anal Precancer among HIV-Infected Men Who Have Sex with Men Epidemiology,Biomarkers&Prevention

P. Castle, T. Lorey, A. Rodriguez, 2012 .

detection to identify anal precancer among HIV-infected men who have sex with men

P. Castle, T. Lorey, A. Rodriguez, 2012 .

A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.

Kanan T. Desai, M. Schiffman, L. Bruni, 2021, Preventive medicine.

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen‐and‐treat strategies to prevent cervical cancer

Nancy Santesso, Marc Arbyn, Lynette Denny, 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Cervical histopathology variability among laboratories: a population-based statewide investigation.

C. Wheeler, M. Schiffman, N. Joste, 2013, American journal of clinical pathology.

The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing

Paul C. Pearlman, Kanan T. Desai, S. Antani, 2021, International journal of cancer.

Perceived Susceptibility to Cervical Cancer among African American Women in the Mississippi Delta: Does Adherence to Screening Matter?

P. Castle, I. Scarinci, J. Gage, 2019, Women's health issues : official publication of the Jacobs Institute of Women's Health.

Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.

M. Schiffman, P. Castle, T. Lorey, 2018, Journal of the National Cancer Institute.

A comparison of cervical histopathology variability using whole slide digitized images versus glass slides: experience with a statewide registry.

Mark Schiffman, William C. Hunt, Cosette M. Wheeler, 2013, Human pathology.

Assuring Adequate Health Insurance: Results of the National Survey of Children With Special Health Care Needs

P. Newacheck, B. Strickland, M. McPherson, 2005, Pediatrics.

The population impact of human papillomavirus/cytology cervical cotesting at 3‐year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen

M. Schiffman, P. Castle, T. Lorey, 2016, Cancer.

A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results

M. Schiffman, H. Erlich, P. Castle, 2014, Journal of Clinical Microbiology.

Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.

M. Schiffman, P. Castle, T. Lorey, 2014, Journal of the National Cancer Institute.

Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

David R. Scott, S. Wacholder, N. Wentzensen, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preventing cervical cancer globally by acting locally: if not now, when?

P. Castle, J. Gage, 2010, Journal of the National Cancer Institute.

Acceptability of self‐collected versus provider‐collected sampling for HPV DNA testing among women in rural El Salvador

P. Castle, I. Scarinci, J. Felix, 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

The age‐specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen‐and‐treat strategies

S. Wacholder, M. Schiffman, N. Wentzensen, 2012, International journal of cancer.

Network Visualization and Pyramidal Feature Comparison for Ablative Treatability Classification Using Digitized Cervix Images

L. R. Long, Kanan T. Desai, M. Schiffman, 2021, Journal of clinical medicine.

J. Cuzick, C. Wheeler, M. Schiffman, 2016, Obstetrics and gynecology.

Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis.

Charles K. Cooper, M. Schiffman, Katie M Smith, 2018, Obstetrics and gynecology.

Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening

M. Schiffman, P. Castle, T. Lorey, 2018, Journal of the National Cancer Institute.

The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy

C. Wheeler, M. Schiffman, P. Castle, 2011, Obstetrics and gynecology.

Visual inspection of the uterine cervix with Acetic Acid (VIA): a critical review and selected articles

C. Ferreccio, J. Gage, 2003 .

Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions

C. Wheeler, M. Schiffman, D. Solomon, 2010, Cancer Epidemiology, Biomarkers & Prevention.

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.

M. Schiffman, P. Castle, T. Raine-Bennett, 2015, Gynecologic oncology.

Detection of precancerous cervical lesions is differential by human papillomavirus type.

C. Wheeler, M. Schiffman, D. Solomon, 2009, Cancer research.

Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program

J. Cuzick, C. Wheeler, M. Schiffman, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

The low risk of precancer after a screening result of human papillomavirus‐negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management

J. Cuzick, M. Schiffman, P. Castle, 2014, Cancer cytopathology.

Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities

C. Wheeler, M. Schiffman, D. Solomon, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.

M. Schiffman, P. Castle, T. Lorey, 2018, Preventive medicine.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

Jack Cuzick, Marc Arbyn, J. Cuzick, 2016, Annals of internal medicine.

Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria

S. Wacholder, M. Schiffman, N. Wentzensen, 2012, International journal of cancer.

Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies

N. Wentzensen, A. Rodriguez, M. Schiffman, 2021, Cancer Prevention Research.

World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia

Nancy Santesso, Holger Schünemann, Paul Blumenthal, 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines

M. Schiffman, N. Wentzensen, P. Castle, 2020, Journal of lower genital tract disease.

Considerations for HPV primary screening in lower-middle income countries.

J. Gage, M. Maza, 2017, Preventive medicine.

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

M. Schiffman, P. Castle, T. Raine-Bennett, 2013, Journal of lower genital tract disease.

Peer activity in the evenings and participation in aggressive and problem behaviors.

M. Overpeck, M. Kogan, T. Nansel, 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Genotyping for HPV 16 and HPV 18 in women with minor cervical 1 lesions : a systematic review and meta-analysis

J. Cuzick, M. Arbyn, A. Szarewski, 2017 .

Use of risk-based cervical screening programs in resource-limited settings.

Jayashree Kalpathy-Cramer, S. de Sanjosé, A. Rodriguez, 2023, Cancer epidemiology.

Treatability by Cryotherapy in a Screen-and-Treat Strategy

M. Schiffman, R. Burk, A. Rodriguez, 2009, Journal of lower genital tract disease.

An Evaluation by Midwives and Gynecologists of Treatability of Cervical Lesions by Cryotherapy Among Human Papillomavirus-Positive Women

M. Schiffman, R. Burk, H. Katki, 2009, International Journal of Gynecologic Cancer.

Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus–Positive Screening Test Results

Kanan T. Desai, Xin He, M. Schiffman, 2022, Journal of lower genital tract disease.

Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing–Based Cervical Screen-and-Treat Program in El Salvador

P. Castle, T. Alonzo, J. Felix, 2020, JCO global oncology.

Evaluation of two alternative ablation treatments for cervical pre-cancer against standard gas-based cryotherapy: a randomized non-inferiority study

P. Castle, T. Alonzo, J. Felix, 2019, International Journal of Gynecological Cancer.

Effects of Maintenance on Quality of Performance of Cryotherapy Devices for Treatment of Precancerous Cervical Lesions

T. Alonzo, J. Felix, R. Figueroa, 2018, Journal of lower genital tract disease.

Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies

Y. Qiao, R. Sankaranarayanan, Xun Zhang, 2020, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Comparison of immediate colposcopy, repeat conventional cytology and high‐risk human papillomavirus testing for the clinical management of atypical squamous cells of undetermined significance cytology in routine health services of Medellin, Colombia: The ASCUS‐COL trial

M. Stoler, P. Castle, R. Herrero, 2020, International journal of cancer.

Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing

J. Cuzick, C. Wheeler, O. Myers, 2017, JAMA oncology.

Five-year prospective evaluation of cytology, HPV testing, and biomarkers for detection of anal precancer in HIV+ MSM.

P. Castle, T. Lorey, R. Landy, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Colposcopic Impression Based on Live Colposcopy and Evaluation of Static Digital Images

M. Schiffman, Katie M Smith, N. Wentzensen, 2016, Journal of lower genital tract disease.

Five-year prospective evaluation of cytology, HPV testing, and biomarkers for detection of anal precancer in HIV+ MSM.

P. Castle, T. Lorey, R. Landy, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analytic and Clinical Performance of cobas HPV Testing in Anal Specimens from HIV-Positive Men Who Have Sex with Men

N. Wentzensen, P. Castle, T. Lorey, 2014, Journal of Clinical Microbiology.

Squamous Intraepithelial Lesions in Cervical Tissue Samples of Limited Adequacy and Insufficient for Grading as Low or High Grade: Outcome, Clinico-Pathological Correlates, and Predictive Role of p16INK4a and Ki67 Biomarker Staining

Sandra Lee, J. Gage, M. Duggan, 2015, Journal of lower genital tract disease.

The Value of Endocervical Curettage in Addition to Biopsies in Women Referred to Colposcopy

M. Schiffman, W. Quint, J. Ordi, 2015, Journal of lower genital tract disease.

Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology

R. E. Stamps, Kai Yu, W. Wheeler, 2018, Journal of the National Cancer Institute.

A Population-Based Study of Visual Inspection With Acetic Acid (VIA) for Cervical Screening in Rural Nigeria

M. Schiffman, N. Wentzensen, R. Burk, 2013, International Journal of Gynecologic Cancer.

Comparative Performance of Human Papillomavirus DNA Testing Using Novel Sample Collection Methods

S. Wacholder, M. Schiffman, P. Castle, 2011, Journal of Clinical Microbiology.

A Population-Based Study of Visual Inspection With Acetic Acid (VIA) for Cervical Screening in Rural Nigeria

M. Schiffman, N. Wentzensen, R. Burk, 2013, International Journal of Gynecologic Cancer.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

J. Cuzick, M. Arbyn, A. Szarewski, 2017, Annals of internal medicine.

The population impact of human papillomavirus/cytology cervical cotesting at 3‐year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen

M. Schiffman, P. Castle, T. Lorey, 2016, Cancer.

World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia

H. Schünemann, N. Santesso, P. Blumenthal, 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

M. Schiffman, P. Castle, T. Lorey, 2013, Journal of lower genital tract disease.

Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detected HPV infection

M. Schiffman, P. Castle, T. Lorey, 2015, International journal of cancer.

Cervical Dysplasia: Original Research Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations Implications for Clinical Guidelines

J. Cuzick, M. Schiffman, P. Castle, 2022 .

Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda

Kanan T. Desai, K. Anastos, P. Castle, 2022, African journal of laboratory medicine.

Treatability by Cryotherapy in a Screen-and-Treat Strategy

M. Schiffman, R. Burk, A. Rodriguez, 2009, Journal of lower genital tract disease.

Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions

M. Schiffman, D. Solomon, P. Castle, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador

P. Castle, Jane J. Kim, J. Felix, 2016, Journal of lower genital tract disease.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test

P. Castle, H. Katki, M. Schiffman, 2015, Cancer Epidemiology, Biomarkers & Prevention.